ENDRA Life Sciences Inc.NDRA
Price as of · delayed, not real-time
A medical technology company developing ultrasound-based imaging solutions for diagnosing and monitoring metabolic diseases, including non-alcoholic fatty liver disease. Its flagship product, the Echosense system, uses proprietary technology to quantify liver fat content non-invasively, positioning it in the emerging digital health and point-of-care diagnostics market. Investors track NDRA for its potential in the growing liver disease diagnostic space, though the company remains in early commercialization stages.
Congressional Interest in ENDRA Life Sciences Inc. (NDRA)
No congressional trades have been disclosed for ENDRA Life Sciences Inc. (NDRA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading NDRA?
No congressional trades found for this stock.